HCL signs $500 mn deal with MSD

NOIDA, INDIA: HCL Technologies Ltd. (HCL), a provider of IT services, today announced it has signed a five-year, $500 million strategic engagement with MSD, a research-driven pharmaceutical company.

HCL would extend its existing relationship with MSD, dating back to 2004, to become an integral business and technology services partner and provide a multitude of services including software-led IT solutions, remote infrastructure management, engineering and business and knowledge process services, said a press release.

“For five years, MSD has leveraged HCL’s extensive expertise in life sciences and healthcare to streamline operational efficiencies and consolidate its IT portfolio,” said Richard G. Branton, vice president of Application Services, MSD.

He added that they continue to leverage global delivery services to meet their business imperatives. They have chosen HCL as their strategic partner due to its deep technology and pharmaceutical domain experience, coupled with the flexibility to engage and a commitment to deliver.

“This is a landmark win for HCL, and we are proud that our growing leadership in pharmaceutical and healthcare, coupled with our previous delivery for MSD has positioned HCL as a strategic partner for MSD,” said Shami Khorana, president, HCL Americas.

He added that they are committed to creating transformational value for MSD in this engagement and they look forward to playing a key role in the organization’s growth across global markets.

MSD would leverage HCL's near-shore delivery network in the U.S. comprising its operations center in Raleigh, North Carolina and its global data center delivery ecosystem, powered by its partner footprints across the globe.

As a result of this engagement, HCL would expand its U.S. team in North Carolina, relying on local hires to staff projects, thus creating jobs for the local community, the release added.